INHIBITION OF THE REGULATION OF INTRACELLULAR PH - POTENTIAL OF 5-(N,N-HEXAMETHYLENE) AMILORIDE IN TUMOR-SELECTIVE THERAPY

被引:39
|
作者
LUO, J
TANNOCK, IF
机构
[1] ONTARIO CANC INST,DEPT MED,TORONTO M4X 1K9,ON,CANADA
[2] ONTARIO CANC INST,DEPT MED BIOPHYS,TORONTO M4X 1K9,ON,CANADA
[3] UNIV TORONTO,TORONTO M4X 1K9,ON,CANADA
关键词
D O I
10.1038/bjc.1994.360
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The viability of cells within the acidic microenvironment found in solid tumours is expected to depend on the regulation of intracellular pH (pH(i)). 5-(N,N-hexamethylene) amiloride (HMA) is a potent inhibitor of the Na+/H+ antiport, a major mechanism for the regulation of pH(i). We have therefore studied the cytotoxicity of HMA in combination with nigericin, a cell-acidifying agent, for EMT-6 cells in monolayer cell culture, in spheroids and in a murine tumour model. The combination of nigericin and HMA was toxic to cells in tissue culture at extracellular pH (pH(e)) less than or equal to 6.8 (as may be found in tumours) but not at pH 7.0 or above (as in most normal tissues). Compared with amiloride, the relative potency of HMA in causing in vitro cytotoxicity (similar to 100-fold) was similar to that for inhibition of the Na+/H+ antiport. The fluorescent probe Hoechst 33342 was used with flow cytometry to study the cytotoxicity of HMA and nigericin at different depths in multicellular tumour spheroids. Only small differences in the level of cell survival were observed, but higher concentrations of HMA were required as compared with those giving equal levels of survival in monolayer culture. The pharmacokinetics of HMA in mice was studied by using high-performance liquid chromatography: after intraperitoneal injection of 20 mu g g(-1), the plasma level of HMA peaked at 8 mu M after about 15 min and decreased to 1 mu M at 120 min; the half-life was 35 min. Nigericin and HMA, at doses of 1.25 mu g g(-1) and 10 mu g g(-1) respectively, failed to cause significant cell killing in the EMT-6 murine tumour, but the surviving fraction was reduced to similar to 0.004 when hydralazine was administered with nigericin and HMA. Local tumour irradiation (15 Gy), followed by treatment with these drugs, led to cell killing that was additive to the effects of drugs and radiation alone, so that hypoxic cells which survived radiation did not appear more sensitive to pH-dependent drug treatment. Acid-mediated therapy can lead to cell death in murine solid tumours, but further measures will be required before the strategy can be exploited clinically.
引用
收藏
页码:617 / 624
页数:8
相关论文
共 34 条
  • [31] ACTIVATION OF 5-[I-125] IODONAPHTHYL-1-AZIDE VIA EXCITATION OF FLUORESCENT (N-(7-NITROBENZ-2-OXA-1,3-DIAZOL-4-YL)) LIPID ANALOGS IN LIVING CELLS - A POTENTIAL TOOL FOR IDENTIFICATION OF COMPARTMENT-SPECIFIC PROTEINS AND PROTEINS INVOLVED IN INTRACELLULAR-TRANSPORT AND METABOLISM OF LIPIDS
    ROSENWALD, AG
    PAGANO, RE
    RAVIV, Y
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1991, 266 (15) : 9814 - 9821
  • [32] Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis
    Ruminski, Peter G.
    Massa, Mark
    Strohbach, Joseph
    Hanau, Cathleen E.
    Schmidt, Michelle
    Scholten, Jeffrey A.
    Fletcher, Theresa R.
    Hamper, Bruce C.
    Carroll, Jeffery N.
    Shieh, Huey S.
    Caspers, Nicole
    Collins, Brandon
    Grapperhaus, Margaret
    Palmquist, Katherine E.
    Collins, Joe
    Baldus, John E.
    Hitchcock, Jeffrey
    Kleine, H. Peter
    Rogers, Michael D.
    McDonald, Joseph
    Munie, Grace E.
    Messing, Dean M.
    Portolan, Silvia
    Whiteley, Laurence O.
    Sunyer, Teresa
    Schnute, Mark E.
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (01) : 313 - 327
  • [33] Discovery of N-(6-Fluoro-1-oxo-1,2-dihydroisoquinolin-7-yl)-5-[(3R)-3-hydroxypyrrolidin-1-yl]thiophene-2-sulfonamide (LSN 3213128), a Potent and Selective Nonclassical Antifolate Aminoimidazole-4-carboxamide Ribonucleotide Formyltransferase (AICARFT) Inhibitor Effective at Tumor Suppression in a Cancer Xenograft Model
    Fales, Kevin R.
    Njoroge, F. George
    Brooks, Harold B.
    Thibodeaux, Stefan
    Torrado, Alicia
    Si, Chong
    Toth, James L.
    Mc Cowan, Jefferson R.
    Roth, Kenneth D.
    Thrasher, Kenneth J.
    Frimpong, Kwame
    Lee, Matthew R.
    Dally, Robert D.
    Shepherd, Timothy A.
    Durham, Timothy B.
    Margolis, Brandon J.
    Wu, Zhipei
    Wang, Yong
    Atwell, Shane
    Wang, Jing
    Hui, Yu-Hua
    Meier, Timothy I.
    Konicek, Susan A.
    Geeganage, Sandaruwan
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (23) : 9599 - 9616
  • [34] Selective inhibition of human cytochrome P450 3A4 by N-[2(R)-hydroxy-1(S)-indanyl]-5-[2(S)-(1,1-dimethylethylaminocarbonyl)-4-[(furo[2,3-B]pyridin-5-yl) methyl]piperazin-1-yl]-4(S)-hydroxy-2(R)-phenylmethylpentanamide and P-glycoprotein by valspodar in gene transfectant systems
    Kawahara, I
    Kato, Y
    Suzuki, H
    Achira, M
    Ito, K
    Crespi, CL
    Sugiyama, Y
    DRUG METABOLISM AND DISPOSITION, 2000, 28 (10) : 1238 - 1243